73 related articles for article (PubMed ID: 28002515)
1. Morphological, imaging and surgical aspects in endometrial endometrioid adenocarcinoma.
Berceanu C; Stepan AE; MehedinŢu C; Cîrstoiu MM; Ciortea R; Berceanu S; Gheonea IA; Brătilă E
Rom J Morphol Embryol; 2016; 57(3):995-1002. PubMed ID: 28002515
[TBL] [Abstract][Full Text] [Related]
2. Molecular profile of grade 3 endometrioid endometrial carcinoma: is it a type I or type II endometrial carcinoma?
Alvarez T; Miller E; Duska L; Oliva E
Am J Surg Pathol; 2012 May; 36(5):753-61. PubMed ID: 22498825
[TBL] [Abstract][Full Text] [Related]
3. Immunoprofile of cervical and endometrial adenocarcinomas using a tissue microarray.
Alkushi A; Irving J; Hsu F; Dupuis B; Liu CL; Rijn M; Gilks CB
Virchows Arch; 2003 Mar; 442(3):271-7. PubMed ID: 12647218
[TBL] [Abstract][Full Text] [Related]
4. Coordinate expression of Cdc25B and ER-alpha is frequent in low-grade endometrioid endometrial carcinoma but uncommon in high-grade endometrioid and nonendometrioid carcinomas.
Wu W; Slomovitz BM; Celestino J; Chung L; Thornton A; Lu KH
Cancer Res; 2003 Oct; 63(19):6195-9. PubMed ID: 14559803
[TBL] [Abstract][Full Text] [Related]
5. New models to predict depth of infiltration in endometrial carcinoma based on transvaginal sonography.
De Smet F; De Brabanter J; Van den Bosch T; Pochet N; Amant F; Van Holsbeke C; Moerman P; De Moor B; Vergote I; Timmerman D
Ultrasound Obstet Gynecol; 2006 Jun; 27(6):664-71. PubMed ID: 16715466
[TBL] [Abstract][Full Text] [Related]
6. Prognostic biomarkers in endometrial adenocarcinoma.
Stănescu AD; Nistor I; Potecă AG; Diţescu D; Comănescu M
Rom J Morphol Embryol; 2014; 55(4):1339-44. PubMed ID: 25611264
[TBL] [Abstract][Full Text] [Related]
7. IMMUNOHISTOCHEMISTRY IN ENDOMETRIAL HYPERPLASIA AND ENDOMETRIAL ADENOCARCINOMA.
Socolov D; Socolov R; Lupascu IA; Rugina V; Gabia O; Garauleanu DM; Carauleanu A
Rev Med Chir Soc Med Nat Iasi; 2016; 120(2):355-62. PubMed ID: 27483717
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.
Geels YP; van der Putten LJ; van Tilborg AA; Lurkin I; Zwarthoff EC; Pijnenborg JM; van den Berg-van Erp SH; Snijders MP; Bulten J; Visscher DW; Dowdy SC; Massuger LF
Gynecol Oncol; 2015 May; 137(2):245-51. PubMed ID: 25773202
[TBL] [Abstract][Full Text] [Related]
9. Endometrial carcinoma in a 15-year-old obese patient with persistent uterine bleeding.
Liu G; Wang Y; Zhang X; Yuan B; Han C; Xue F
Gynecol Endocrinol; 2014 Apr; 30(4):277-9. PubMed ID: 24456540
[TBL] [Abstract][Full Text] [Related]
10. Should grade 3 endometrioid endometrial carcinoma be considered a type 2 cancer-a clinical and pathological evaluation.
Voss MA; Ganesan R; Ludeman L; McCarthy K; Gornall R; Schaller G; Wei W; Sundar S
Gynecol Oncol; 2012 Jan; 124(1):15-20. PubMed ID: 21864888
[TBL] [Abstract][Full Text] [Related]
11. High concordance of molecular tumor alterations between pre-operative curettage and hysterectomy specimens in patients with endometrial carcinoma.
Stelloo E; Nout RA; Naves LC; Ter Haar NT; Creutzberg CL; Smit VT; Bosse T
Gynecol Oncol; 2014 May; 133(2):197-204. PubMed ID: 24556061
[TBL] [Abstract][Full Text] [Related]
12. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
[TBL] [Abstract][Full Text] [Related]
13. [Significance of phosphoinositide 3 kinase/AKT pathway alterations in endometrial carcinoma].
Yang X; Dong Y; Zhang XM; Liang Y; Zhang Y; Meng YT; Wang Y; Wang W; Nong L; Li T; Liao QP
Zhonghua Bing Li Xue Za Zhi; 2011 Dec; 40(12):799-804. PubMed ID: 22336203
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of transvaginal ultrasound for the evaluation of myometrial invasion in endometrial carcinoma.
Ruangvutilert P; Sutantawibul A; Sunsaneevithayakul P; Boriboonhirunsarn D; Chuenchom T
J Med Assoc Thai; 2004 Jan; 87(1):47-52. PubMed ID: 14971534
[TBL] [Abstract][Full Text] [Related]
15. Endometrial stromal sarcoma with endometrioid adenocarcinoma of the uterus: a case report.
Liu G; Zhang C; Ma Z; Zhang Q; Liu B
Int J Clin Exp Pathol; 2015; 8(5):5242-6. PubMed ID: 26191224
[TBL] [Abstract][Full Text] [Related]
16. How to improve the preoperative staging of presumed early-stage endometrioid endometrial cancer?
Bleu G; Arsène E; Merlot B; Kerdraon O; Bigot J; Boulanger L; Dedet B; Vinatier D; Collinet P
Eur J Gynaecol Oncol; 2015; 36(6):698-702. PubMed ID: 26775355
[TBL] [Abstract][Full Text] [Related]
17. Agreement between preoperative transvaginal ultrasound and intraoperative macroscopic examination for assessing myometrial infiltration in low-risk endometrioid carcinoma.
Pineda L; Alcázar JL; Caparrós M; Mínguez JA; Idoate MA; Quiceno H; Solórzano JL; Jurado M
Ultrasound Obstet Gynecol; 2016 Mar; 47(3):369-73. PubMed ID: 26033260
[TBL] [Abstract][Full Text] [Related]
18. L1CAM Expression is Related to Non-Endometrioid Histology, and Prognostic for Poor Outcome in Endometrioid Endometrial Carcinoma.
Geels YP; Pijnenborg JM; Gordon BB; Fogel M; Altevogt P; Masadah R; Bulten J; van Kempen LC; Massuger LF
Pathol Oncol Res; 2016 Oct; 22(4):863-8. PubMed ID: 26891628
[TBL] [Abstract][Full Text] [Related]
19. The sensitivity and specificity of a new formula to distinguish endometrioid type endometrial carcinoma from ovarian endometrial carcinoma.
Nishimura S; Ito YM; Tsuda H; Ohnishi Y; Kataoka F; Nomura H; Chiyoda T; Suzuki A; Susumu N; Aoki D; Hatae M
Eur J Obstet Gynecol Reprod Biol; 2010 Jan; 148(1):67-72. PubMed ID: 19815329
[TBL] [Abstract][Full Text] [Related]
20. Paraneoplastic cerebellar degeneration and endometrial cancer: a rare occurrence.
Karpathiou G; Da Cruz V; Casteillo F; Corsini T; Paul S; Peyron R; Forest F; Peoc'h M
Pathology; 2016 Apr; 48(3):275-8. PubMed ID: 27020505
[No Abstract] [Full Text] [Related]
[Next] [New Search]
